Netupitant/palonosetron (trade name Akynzeo) is a fixed dose combination drug for prevention of acute and delayed chemotherapy-induced nausea and vomiting. Netupitant is an NK1 receptor antagonist and palonosetron is a 5-HT3 receptor antagonist...Wikipedia

 

 

Manufacturer's Website: Akynzeo

 

 

 Average retail cost: $583/dose

Search Terms: Akynzeo, netupitant‐palonosetron, nausea and vomiting, chemotherapy-induced